Results 51 to 60 of about 471 (127)

In vitro activity of cefepime-enmetazobactam on carbapenem-resistant Gram negatives

open access: yesClinical Microbiology and Infection
Cefepime-enmetazobactam is a new β-lactam/βlactamase inhibitor combination with broad-spectrum activity against multidrug-resistant Enterobacterales, including extended-spectrum β-lactamase producers. This study evaluated the in vitro activity of cefepime-enmetazobactam towards a collection of carbapenem-resistant Enterobacterales (CRE), Pseudomonas ...
Bonnin, Rémy   +4 more
openaire   +3 more sources

A review of antibiotic safety in pregnancy—2025 update

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 4, Page 227-237, April 2025.
Abstract Antibiotics constitute the majority of prescriptions for women during pregnancy. Common bacterial infections, including urinary tract infections, skin and soft tissue infections, and upper and lower respiratory tract infections, are expected in pregnancy, similar to the general public.
Johny Nguyen   +8 more
wiley   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 7, Page 1416-1445, April 2025.
Abstract In the past year, the European Medicines Agency (EMA), the Food and Drug Administration (FDA) and the Medicines and Healthcare Products Regulatory Agency (MHRA) authorised 53 novel drugs. While the 2024 harvest is not as rich as in 2023, when 70 new chemical entities were approved, the number of ‘orphan’ drug authorisations in 2024 (21) is ...
Stavros Topouzis   +16 more
wiley   +1 more source

How Clavulanic Acid Inhibits Serine β‐Lactamases

open access: yesChemBioChem, Volume 25, Issue 22, November 18, 2024.
Inhibition of serine β‐lactamases by clavulanic acid occurs via a bifurcating mechanism. The formation of an acyl‐enzyme complex may be followed by hydrolysis, or oxazolidine ring opening and subsequent decarboxylation to give more stable species. Further fragmentation is slow and is less likely to be biologically relevant in inhibition.
Pauline A. Lang   +6 more
wiley   +1 more source

Cefepime-Enmetazobactam: a novel β-Lactam/β-Lactamase inhibitor combination for complicated urinary tract infections [PDF]

open access: yes
Complicated urinary tract infections (cUTIs) represent a significant global health challenge, particularly with the rising prevalence of extended-spectrum β-lactamase (ESBL)-producing pathogens.
Balaji, Vikram   +4 more
core   +1 more source

Nephrotoxicity of New Antibiotics: A Systematic Review

open access: yesToxics
Drug-induced nephrotoxicity is a common and serious problem in clinical practice. We conducted a systematic review of studies reporting nephrotoxicity events associated with antibiotics approved since 2018.
Panagiotis Stathopoulos   +3 more
doaj   +1 more source

Role of new antibiotics in extended-spectrum β-lactamase-, AmpC- infections

open access: yes, 2021
PURPOSE OF REVIEW: Extended-spectrum β-lactamases (ESBL)- and ampicillinase class C (AmpC)-producing Enterobacterales represent one of the major public threats of the current era. As a consequence, during the last decades there have been great efforts to
Bassetti M.   +15 more
core   +2 more sources

Cefepime/enmetazobactam steady-state concentrations in spondylodiscitis-relevant tissues: an experimental porcine study

open access: yesEuropean Spine Journal
Abstract Background Spondylodiscitis is a severe infection associated with considerable morbidity and mortality. The prevalence of gram-negative infections is on the rise, posing significant therapeutic challenges.
Nielsen, Maria Bech Damsgaard   +9 more
openaire   +2 more sources

Combating antimicrobial resistance in ESBL- and AmpC-producing Enterobacterales: In vitro evaluation of cefepime–enmetazobactam

open access: yesIndian Journal of Medical Microbiology
To evaluate the in-vitro activity of cefepime-enmetazobactam (FEP-EMT)-a novel β-lactam-β-lactamase inhibitor (BL/BLI) combination against Extended-spectrum β-lactamase (ESBL)- and AmpC β-lactamase (AmpC)- producing Enterobacterales isolated from diverse clinical samples.
Pooja Haleangadi   +2 more
openaire   +2 more sources

HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF ENMETAZOBACTAM AND CEFEPIME [PDF]

open access: yes
The present study aimed to develop and validate a simple, precise, accurate, and robust reverse-phase high-performance liquid chromatography (RP-HPLC) method for the simultaneous estimation of Enmetazobactam (EMB) and Cefepime (CFP) in bulk and ...
Udit Narain Soni, Nidhi Sahu
core   +2 more sources

Home - About - Disclaimer - Privacy